James A. McEwen
Founder at Medical Device Development Centre
Profile
Dr. James A.
McEwen is a Director at Medical Device Development Centre and Chairman at Sirius Genomics, Inc. He is on the Board of Directors at Medical Device Development Centre.
Dr. McEwen was previously employed as Head-Biomedical Engineering Department by Vancouver Hospital & Health Sciences Centre.
He received his doctorate degree from the University of British Columbia.
James A. McEwen active positions
| Companies | Position | Start |
|---|---|---|
| Medical Device Development Centre | Founder | 01/01/1990 |
Former positions of James A. McEwen
| Companies | Position | End |
|---|---|---|
| Vancouver Hospital & Health Sciences Centre | Corporate Officer/Principal | 01/01/1990 |
Sirius Genomics, Inc.
 Sirius Genomics, Inc. Pharmaceuticals: MajorHealth Technology Sirius Genomics, Inc. develops DNA-based diagnostic and pharmacogenetic products. Its product is Sepsis. It also develops companion diagnostics, that are closely tied to therapeutic decisions, leading to better patient outcomes through personalized medicine. Sirius generates value by improving the safety and effectiveness of pharmaceutical compounds. The company correlates patient genetics with clinical outcomes, leading to proprietary and commercially viable CDx products. Sirius Genomics was founded by James A. Russell and Keith Walley in 2001 and is headquartered in Vancouver, Canada. | Chairman | - |
Training of James A. McEwen
| University of British Columbia | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Sirius Genomics, Inc.
Sirius Genomics, Inc. Pharmaceuticals: MajorHealth Technology Sirius Genomics, Inc. develops DNA-based diagnostic and pharmacogenetic products. Its product is Sepsis. It also develops companion diagnostics, that are closely tied to therapeutic decisions, leading to better patient outcomes through personalized medicine. Sirius generates value by improving the safety and effectiveness of pharmaceutical compounds. The company correlates patient genetics with clinical outcomes, leading to proprietary and commercially viable CDx products. Sirius Genomics was founded by James A. Russell and Keith Walley in 2001 and is headquartered in Vancouver, Canada. | Health Technology |
| Medical Device Development Centre | |
| Vancouver Hospital & Health Sciences Centre |
- Stock Market
- Insiders
- James A. McEwen
